Rathbones Group PLC Johnson & Johnson Transaction History

Rathbones Group PLC

$17.8 Billion
Q2 2024

A detailed history of Rathbones Group PLC transactions in Johnson & Johnson stock. As of the latest transaction made, Rathbones Group PLC holds 1,237,143 shares of JNJ stock, worth $206 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

1,237,143

Previous 1,304,421 5.16%

Holding current value

$206 Million

Previous $206 Million 12.37%

% of portfolio

1.02%

Previous 1.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$144.38 - $157.78 $9.71 Million - $10.6 Million	-67,278 Reduced 5.16%	1,237,143 $181 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $1.9 Million - $1.99 Million	-12,256 Reduced 0.93%	1,304,421 $206 Million
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $674,128 - $735,614	4,630 Added 0.35%	1,316,677 $206 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $86.1 Million - $96.5 Million	552,882 Added 72.83%	1,312,047 $204 Million
Q2 2023 Aug 04, 2023	SELL	$154.35 - $166.11 $5.67 Million - $6.1 Million	-36,752 Reduced 4.62%	759,165 $126 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $5.03 Million - $6 Million	33,309 Added 4.37%	795,917 $123 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $650,091 - $729,587	4,058 Added 0.53%	762,608 $135 Million
Q3 2022 Nov 03, 2022	BUY	$161.33 - $179.52 $8.14 Million - $9.06 Million	50,460 Added 7.13%	758,550 $124 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $22.7 Million - $25.1 Million	135,067 Added 23.57%	708,090 $126 Million
Q1 2022 May 11, 2022	BUY	$158.14 - $179.59 $3.49 Million - $3.97 Million	22,084 Added 4.01%	573,023 $102 Million
Q4 2021 Feb 10, 2022	BUY	$155.93 - $173.01 $1.06 Million - $1.17 Million	6,771 Added 1.24%	550,939 $94.2 Million
Q3 2021 Nov 04, 2021	BUY	$161.5 - $179.47 $7.83 Million - $8.7 Million	48,455 Added 9.77%	544,168 $87.9 Million
Q2 2021 Jul 30, 2021	BUY	$159.48 - $171.07 $1.72 Million - $1.85 Million	10,793 Added 2.23%	495,713 $81.7 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $3.39 Million - $3.78 Million	22,174 Added 4.79%	484,920 $79.7 Million
Q4 2020 Feb 11, 2021	BUY	$137.11 - $157.38 $1.53 Million - $1.75 Million	11,141 Added 2.47%	462,746 $72.8 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $3.18 Million - $3.49 Million	22,671 Added 5.29%	451,605 $67.2 Million
Q2 2020 Aug 07, 2020	BUY	$128.81 - $155.51 $9.07 Million - $10.9 Million	70,377 Added 19.63%	428,934 $60.3 Million
Q1 2020 May 04, 2020	BUY	$111.14 - $153.99 $6.09 Million - $8.43 Million	54,774 Added 18.03%	358,557 $47 Million
Q4 2019 Feb 11, 2020	SELL	$127.5 - $146.44 $124,822 - $143,364	-979 Reduced 0.32%	303,783 $44.3 Million
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $9.46 Million - $10.6 Million	74,542 Added 32.38%	304,762 $39.4 Million
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $25,967 - $28,559	-198 Reduced 0.09%	230,220 $32.1 Million
Q1 2019 May 09, 2019	SELL	$125.72 - $139.79 $680,648 - $756,823	-5,414 Reduced 2.3%	230,418 $32.2 Million
Q4 2018 Feb 12, 2019	BUY	$122.84 - $147.84 $1.27 Million - $1.53 Million	10,341 Added 4.59%	235,832 $30.4 Million
Q3 2018 Oct 12, 2018	BUY	$121.58 - $142.88 $901,880 - $1.06 Million	7,418 Added 3.4%	225,491 $31.2 Million
Q2 2018 Jul 16, 2018	SELL	$119.4 - $131.76 $1.39 Million - $1.53 Million	-11,645 Reduced 5.07%	218,073 $26.5 Million
Q1 2018 Apr 06, 2018	SELL	$125.1 - $148.14 $1.83 Million - $2.16 Million	-14,592 Reduced 5.97%	229,718 $29.4 Million
Q4 2017 Jan 24, 2018	SELL	$131.22 - $143.62 $1.02 Million - $1.12 Million	-7,805 Reduced 3.1%	244,310 $34.1 Million
Q3 2017 Oct 24, 2017	BUY	$129.47 - $135.38 $32.6 Million - $34.1 Million	252,115	252,115 $32.8 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Johnson & Johnson Transaction History